Leonteq Securities »

Fate Therapeutics shares owned by Leonteq Securities

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Leonteq Securities from 13F filings

Historical chart of Leonteq Securities investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Leonteq Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Leonteq Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $19 19 1.00
2025-03-31 $15 19 0.79
2024-12-31 $31 19 1.63

More positions owned by Leonteq Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Meta Platforms Cl A Put Option (META)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Stellantis SHS (STLA)
Micron Technology (MU)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Citigroup Com New Put Option (C)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for Leonteq Securities

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vestal Point Capital
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management
AQR Capital Management

View all funds holding Fate Therapeutics